Clinical Trial

Herbs & Supplements in Breast Cancer Usage, Impact, and Personalized Approaches for Diverse Populations

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This research study is enrolling participants diagnosed with breast cancer and receiving/received chemotherapy and/or endocrine therapy. The study's primary objective is to assess the differences in the use of herbs and supplements among the populations served at Cleveland Clinic Florida and Ohio by administering a participant-reported questionnaire.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-04-11; most recent amendment 2026-04-27.
Trial Details
NCT Number NCT06926530
Lead Sponsor Case Comprehensive Cancer Center
Conditions Breast Cancer, Breast Cancer Stage I, Breast Cancer Stage II, Breast Cancer Stage III, Breast Carcinoma
Enrollment 240 participants
Start Date 2026-06
Primary Completion 2027-03 (estimated)
Study Completion 2027-03 (estimated)
Updated on ClinicalTrials.gov 2026-04-30